Park Avenue Compounding recalls

Park Avenue Compounding has 2 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 10 Dec 2025. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls2since 2025

Last 12 months2reported

Class I00% of total

Ongoing2latest 10 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 1 1 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why park avenue compounding is recalled

Manufacturing (CGMP) Deviations2100%

Product types

Cold & Cough Medicine150%
Pain Medication150%

By year

20252100%

Ongoing park avenue compounding recalls

2 active

Reported	Class	Recall	Company	Reason	Where
10 Dec 2025Drug	CLASS II	Phenylephrine HCI, 1000 mcg / Total Volume recalled	Park Avenue Compounding	Manufacturing (CGMP) Deviations	MO
26 Nov 2025Drug	CLASS II	Fentanyl citrate, 2 mcg / ml / Ropivacaine, 2% in NS, CII recalled	Park Avenue Compounding	Manufacturing (CGMP) Deviations	MO

All park avenue compounding recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
10 Dec 2025Drug	CLASS II	Phenylephrine HCI, 1000 mcg / Total Volume recalled	Park Avenue Compounding	Manufacturing (CGMP) Deviations	MO
26 Nov 2025Drug	CLASS II	Fentanyl citrate, 2 mcg / ml / Ropivacaine, 2% in NS, CII recalled	Park Avenue Compounding	Manufacturing (CGMP) Deviations	MO

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.